When we look at how much money they make before expenses, they keep 0.978% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -3.272%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -3.594%. This tells us they're good at keeping money after all costs.
Return on Investments
The company's asset efficiency, represented by a robust -0.257% return, is a testament to CymaBay Therapeutics, Inc.'s adeptness in optimizing resource deployment. CymaBay Therapeutics, Inc.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -0.538%. Furthermore, the proficiency of CymaBay Therapeutics, Inc. in capital utilization is underscored by a remarkable -0.256% return on capital employed.
Stock Prices
CymaBay Therapeutics, Inc.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $32.35, while its low point bottomed out at $32.19. This variance in figures offers investors a lucid insight into the roller-coaster ride that is CymaBay Therapeutics, Inc.'s stock market.
Liquidity Ratios
Analyzing CBAY liquidity ratios reveals its financial health of the firm.
The current ratio of 1096.01% gauges short-term asset coverage for liabilities.
The quick ratio (1070.09%) assesses immediate liquidity, while the cash ratio (560.58%) indicates cash reserves.
cards.indicator
cards.value
Current Ratio
1096.01%
Quick Ratio
1070.09%
Cash Ratio
560.58%
Profitability Ratios
CBAY profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -339.10% underscores its earnings before tax deductions.
The effective tax rate stands at -11.38%, revealing its tax efficiency.
The net income per EBT, 105.98%, and the EBT per EBIT, 103.63%, provide insights into its earnings hierarchy.
Lastly, with an EBIT per revenue ratio of -327.23%, we grasp its operational profitability.
cards.indicator
cards.value
Pretax Profit Margin
-339.10%
Effective Tax Rate
-11.38%
Net Income per EBT
105.98%
EBT per EBIT
103.63%
EBIT per Revenue
-327.23%
Operational Efficiency
Operational metrics shed light on its business agility. With an operating cycle of 10.96, it details the span from stock purchase to revenue.
The 11 days it takes to settle debts showcases its creditor relations.
cards.indicator
cards.value
Days of Sales Outstanding
1070
Days of Payables Outstanding
2052
Cash Conversion Cycle
-2052
Payables Turnover
0.18
Fixed Asset Turnover
5.43
Asset Turnover
0.07
Cash Flow Ratios
Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -0.64, and free cash flow per share, -0.64, depict cash generation on a per-share basis.
The cash per share value, 3.48, showcases liquidity position.
Lastly, the operating cash flow sales ratio, -2.33, offers insight into cash flow relative to sales.
cards.indicator
cards.value
Operating Cash Flow per Share
-0.64
Free Cash Flow per Share
-0.64
Cash per Share
3.48
Operating Cash Flow Sales Ratio
-2.33
Free Cash Flow to Operating Cash Flow Ratio
1.01
Cash Flow Coverage Ratio
-0.66
Short Term Coverage Ratio
-7.25
Capital Expenditure Coverage Ratio
-162.99
Dividend Paid and Capex Coverage Ratio
-162.99
Debt and Leverage Ratios
Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 25.12%, highlights its total liabilities relative to assets.
With a debt-equity ratio of 0.37, we discern the balance between debt and equity financing.
The long-term debt to capitalization, 25.34%, and total debt to capitalization, 27.20%, ratios shed light on its capital structure.
An interest coverage of -10.98 indicates its ability to manage interest expenses.
cards.indicator
cards.value
Debt Ratio
25.12%
Debt Equity Ratio
0.37
Long Term Debt to Capitalization
25.34%
Total Debt to Capitalization
27.20%
Interest Coverage
-10.98
Cash Flow to Debt Ratio
-0.66
Company Equity Multiplier
1.49
Per Share Data
Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 0.29, provides a glimpse into top-line earnings distributed across each share.
Net income per share, -0.99, reflects the portion of profit attributed to each share.
The book value per share, 2.75, represents the net asset value distributed per share, while the tangible book value per share, 2.75, excludes intangible assets.
cards.indicator
cards.value
Revenue Per Share
0.29
Net Income Per Share
-0.99
Book Value Per Share
2.75
Tangible Book Value Per Share
2.75
Shareholders Equity Per Share
2.75
Interest Debt Per Share
1.21
Growth Ratios
EBIT growth, -9.20%, and operating income growth, -9.20%, offer insights into operational profitability progression.
The net income growth, 11.37%, showcases bottom-line expansion, and the EPS growth, 27.21%, measures the growth in earnings per share.
cards.indicator
cards.value
Gross Profit Growth
4380.56%
EBIT Growth
-9.20%
Operating Income Growth
-9.20%
Net Income Growth
11.37%
EPS Growth
27.21%
EPS Diluted Growth
26.67%
Weighted Average Shares Growth
21.23%
Weighted Average Shares Diluted Growth
20.96%
Dividends per Share Growth
-100.00%
Operating Cash Flow Growth
13.74%
Free Cash Flow Growth
13.36%
10-Year Operating CF Growth per Share
-13.56%
5-Year Operating CF Growth per Share
28.14%
3-Year Operating CF Growth per Share
-5.20%
10-Year Net Income Growth per Share
-38.53%
5-Year Net Income Growth per Share
20.94%
3-Year Net Income Growth per Share
-40.45%
10-Year Shareholders Equity Growth per Share
108.13%
5-Year Shareholders Equity Growth per Share
-6.65%
3-Year Shareholders Equity Growth per Share
32.85%
Asset Growth
206.44%
Book Value per Share Growth
566.79%
Debt Growth
25.93%
R&D Expense Growth
17.83%
SGA Expenses Growth
106.85%
Other Metrics
Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 2,416,503,928.26, captures the company's total value, considering both debt and equity.
Income quality, 0.69, assesses the reliability of reported earnings.
The sales, general, and administrative to revenue ratio, 1.67, gauges operational efficiency, while the research and development to revenue, 257.84%, highlights investment in innovation.
cards.indicator
cards.value
Enterprise Value
2,416,503,928.26
Income Quality
0.69
Sales General and Administrative to Revenue
1.67
Research and Development to Revenue
257.84%
Capex to Operating Cash Flow
0.61%
Capex to Revenue
-1.43%
Capex to Depreciation
-65.35%
Stock-Based Compensation to Revenue
49.01%
Graham Number
7.84
Return on Tangible Assets
-24.24%
Graham Net Net
2.37
Working Capital
366,959,000
Tangible Asset Value
292,256,000
Net Current Asset Value
261,372,000
Average Payables
2,462,000
Days Payables Outstanding
2052
ROIC
-25.00%
ROE
-0.36%
Valuation Ratios
Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 12.59, and the price to book ratio, 12.59, reflect the market's valuation relative to the company's book value.
The price to sales ratio, 119.98, provides a perspective on valuation in relation to sales.
Ratios like price to free cash flows, -51.09, and price to operating cash flows, -50.75, gauge market valuation against cash flow metrics.
cards.indicator
cards.value
Price Book Value Ratio
12.59
Price to Book Ratio
12.59
Price to Sales Ratio
119.98
Price Cash Flow Ratio
-50.75
Enterprise Value Multiple
-40.30
Price Fair Value
12.59
Price to Operating Cash Flow Ratio
-50.75
Price to Free Cash Flows Ratio
-51.09
Price to Tangible Book Ratio
8.58
Enterprise Value to Sales
77.77
Enterprise Value Over EBITDA
-23.93
EV to Operating Cash Flow
-33.32
Earnings Yield
-4.20%
Free Cash Flow Yield
-2.91%
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
